ArticleMedical hypothesis, discovery & innovation ophthalmology journal2022

Safety and efficacy of topical tacrolimus 0.03% in the management of vernal keratoconjunctivitis: a non-randomized controlled clinical trial.

Mahmoud Eltagoury et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.